Aclaris Therapeutics (ACRS) has an average rating of buy and mean price target of $10.58, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
DNB Carnegie on Monday increased its price target for oil tanker company Frontline (FRO.OL) to 430 Norwegian kroner from 390 kroner, while maintaining its hold rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Deutsche Bank on Sunday reiterated its hold rating on industrial technology company Hexagon (HEXA-B.ST) and raised its price target to 95 kronor from 85 kronor.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
UBS on Monday raised the price target for chocolate and cocoa products company Barry Callebaut (BARN.SW) to 1,180.00 francs from 1,100.00 francs and kept its rating at neutral.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)